Header Logo

Connection

CHRIS AMOS to Risk

Back to Details
This is a "connection" page, showing publications CHRIS AMOS has written about Risk.
CHRIS AMOS
Connection Strength
1.200
Risk
  1. Heritable Traits and Lung Cancer Risk: A Two-Sample Mendelian Randomization Study. Cancer Epidemiol Biomarkers Prev. 2023 10 02; 32(10):1421-1435.
    View in: PubMed
    Score: 0.179
  2. Tumor somatic mutations also existing as germline polymorphisms may help to identify functional SNPs from genome-wide association studies. Carcinogenesis. 2020 10 15; 41(10):1353-1362.
    View in: PubMed
    Score: 0.145
  3. Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet. 2011 Jul 01; 20(13):2673-9.
    View in: PubMed
    Score: 0.075
  4. Power analysis for case-control association studies of samples with known family histories. Hum Genet. 2010 Jun; 127(6):699-704.
    View in: PubMed
    Score: 0.070
  5. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. EBioMedicine. 2024 Feb; 100:104991.
    View in: PubMed
    Score: 0.046
  6. Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model. Cancer. 2024 03 01; 130(5):770-780.
    View in: PubMed
    Score: 0.045
  7. Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics. Int J Cancer. 2020 02 01; 146(3):739-748.
    View in: PubMed
    Score: 0.033
  8. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2018 07; 50(7):928-936.
    View in: PubMed
    Score: 0.031
  9. Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol Carcinog. 2018 02; 57(2):216-224.
    View in: PubMed
    Score: 0.030
  10. Functional variants in DCAF4 associated with lung cancer risk in European populations. Carcinogenesis. 2017 05 01; 38(5):541-551.
    View in: PubMed
    Score: 0.029
  11. Telomere structure and maintenance gene variants and risk of five cancer types. Int J Cancer. 2016 Dec 15; 139(12):2655-2670.
    View in: PubMed
    Score: 0.027
  12. Genetic Risk Can Be Decreased: Quitting Smoking Decreases and Delays Lung Cancer for Smokers With High and Low CHRNA5 Risk Genotypes - A Meta-Analysis. EBioMedicine. 2016 Sep; 11:219-226.
    View in: PubMed
    Score: 0.027
  13. Novel Association of Genetic Markers Affecting CYP2A6 Activity and Lung Cancer Risk. Cancer Res. 2016 10 01; 76(19):5768-5776.
    View in: PubMed
    Score: 0.027
  14. Genetic variant in DNA repair gene GTF2H4 is associated with lung cancer risk: a large-scale analysis of six published GWAS datasets in the TRICL consortium. Carcinogenesis. 2016 09; 37(9):888-896.
    View in: PubMed
    Score: 0.027
  15. History of chickenpox in glioma risk: a report from the glioma international case-control study (GICC). Cancer Med. 2016 06; 5(6):1352-8.
    View in: PubMed
    Score: 0.026
  16. Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study. Hum Mol Genet. 2015 Sep 15; 24(18):5356-66.
    View in: PubMed
    Score: 0.025
  17. 15q12 variants, sputum gene promoter hypermethylation, and lung cancer risk: a GWAS in smokers. J Natl Cancer Inst. 2015 Feb 23; 107(5).
    View in: PubMed
    Score: 0.025
  18. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Hum Mol Genet. 2014 Dec 15; 23(24):6616-33.
    View in: PubMed
    Score: 0.024
  19. Axonal guidance signaling pathway interacting with smoking in modifying the risk of pancreatic cancer: a gene- and pathway-based interaction analysis of GWAS data. Carcinogenesis. 2014 May; 35(5):1039-45.
    View in: PubMed
    Score: 0.023
  20. Simplifying clinical use of the genetic risk prediction model BRCAPRO. Breast Cancer Res Treat. 2013 Jun; 139(2):571-9.
    View in: PubMed
    Score: 0.022
  21. Hierarchical modeling identifies novel lung cancer susceptibility variants in inflammation pathways among 10,140 cases and 11,012 controls. Hum Genet. 2013 05; 132(5):579-89.
    View in: PubMed
    Score: 0.021
  22. Association between functional polymorphisms in genes involved in the MAPK signaling pathways and cutaneous melanoma risk. Carcinogenesis. 2013 Apr; 34(4):885-92.
    View in: PubMed
    Score: 0.021
  23. Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls. Hum Mol Genet. 2012 Nov 15; 21(22):4980-95.
    View in: PubMed
    Score: 0.021
  24. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet. 2012 May 06; 44(6):651-8.
    View in: PubMed
    Score: 0.020
  25. Smoking and genetic risk variation across populations of European, Asian, and African American ancestry--a meta-analysis of chromosome 15q25. Genet Epidemiol. 2012 May; 36(4):340-51.
    View in: PubMed
    Score: 0.020
  26. Association of a novel functional promoter variant (rs2075533 C>T) in the apoptosis gene TNFSF8 with risk of lung cancer--a finding from Texas lung cancer genome-wide association study. Carcinogenesis. 2011 Apr; 32(4):507-15.
    View in: PubMed
    Score: 0.019
  27. Mediating effects of smoking and chronic obstructive pulmonary disease on the relation between the CHRNA5-A3 genetic locus and lung cancer risk. Cancer. 2010 Jul 15; 116(14):3458-62.
    View in: PubMed
    Score: 0.018
  28. A second genetic variant on chromosome 15q24-25.1 associates with lung cancer. Cancer Res. 2010 Apr 15; 70(8):3128-35.
    View in: PubMed
    Score: 0.018
  29. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res. 2009 Aug 15; 69(16):6633-41.
    View in: PubMed
    Score: 0.017
  30. BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model. J Clin Oncol. 2007 Oct 10; 25(29):4635-41.
    View in: PubMed
    Score: 0.015
  31. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007 Sep 06; 357(10):977-86.
    View in: PubMed
    Score: 0.015
  32. Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population. Cancer Epidemiol Biomarkers Prev. 2007 Sep; 16(9):1753-9.
    View in: PubMed
    Score: 0.015
  33. Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. Clin Cancer Res. 2007 May 15; 13(10):3100-4.
    View in: PubMed
    Score: 0.014
  34. CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn's disease. Am J Gastroenterol. 2004 Feb; 99(2):306-15.
    View in: PubMed
    Score: 0.011
  35. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst. 2001 Jul 18; 93(14):1106-8.
    View in: PubMed
    Score: 0.010
  36. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract. J Natl Cancer Inst. 1998 Sep 16; 90(18):1393-9.
    View in: PubMed
    Score: 0.008
  37. Description of a large pedigree with an adverse lipoprotein cholesterol phenotype: the Bogalusa Heart Study. Genet Epidemiol. 1986; 3(4):241-53.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.